The Angeles Clinic and Research Institute| May 21, 2026

Advances in Melanoma Care: A Multidisciplinary Symposium
Host: The Angeles Clinic and Research Institute (A Cedars-Sinai Affiliate)
Date: Thursday, May 21, 2026 Time: 4:00 PM PT / 5:00 PM MT / 6:00 PM CT / 7:00 PM ET
This symposium brings together leading melanoma specialists from The Angeles Clinic, Memorial Sloan Kettering, and Massachusetts General Hospital for a comprehensive afternoon program covering the full spectrum of melanoma care — from surgical and adjuvant approaches through cutting-edge cellular and targeted therapies, with dedicated patient resources and a Q&A session to close.
The program features a strong multidisciplinary lineup — combining medical oncology, surgical oncology, and cellular therapy expertise — anchored by The Angeles Clinic team (Drs. Hamid, Mehmi, Fischer, and Faries) with national experts from MSK (Dr. Smithy) and Mass General (Dr. Sullivan), plus patient-advocacy representation from AIM at Melanoma.
Key Themes Covered
- Treatment sequencing: Adjuvant and neoadjuvant strategies, both medical and surgical
- Immunotherapy frontier: T-cell therapies and first-line systemic options
- Precision medicine: Targeted therapies for actionable mutations
- Special populations: Uveal melanoma and other rare subtypes
- What’s next: Novel and emerging therapeutics
- Patient support: Community resources via AIM at Melanoma
The symposium runs approximately 2 hours 40 minutes, concluding with an open Q&A for attendees.
Presenters & Topics
4:00 PM PT
Welcome and Introductions
Omid Hamid, MD
Co-Director of Cutaneous Oncology
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
4:10 PM PT
Adjuvant/Neo Adjuvant Therapeutic Considerations
Inderjit Mehmi, MD
Medical Oncologist
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
4:30 PM PT
(Neo) Adjuvant and Metastatic Surgical Considerations
Trevan Fischer, MD
Surgical Oncologist
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
4:50 PM PT
T cell Therapies
Mark Faries, MD
Director of Surgical Oncology
The Angeles Clinic & Research Institute, A Cedars Sinai Affiliate
5:10 PM PT
First Line Therapies
James Smithy, MD
Medical Oncologist and Cellular Therapist
Memorial Sloan Kettering Cancer Center
5:30 PM PT
Targeted Therapies
Ryan Sullivan, MD
Director
Center for Melanoma
Massachusetts General Hospital
5:50 PM PT
Uveal Melanoma & Rare Melanomas
Inderjit Mehmi, MD
Medical Oncologist
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
6:10 PM PT
Novel Therapeutics in Melanoma
Omid Hamid, MD
Co-Director of Cutaneous Oncology
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
6:30 PM PT
AIM at Melanoma Patient Resources
Ann Garst Taylor, CVA
Director Community Engagement
AIM at Melanoma
6:40 PM PT
Q&A & Closing Remarks

